CADAS138 emerges as a novel therapeutic target in the realm of inflammatory conditions. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are diligently pursuing the functional roles of CADAS138 in disease pathogenesis, paving the way for the development of novel t… Read More